Consolidated revenues of $111.0 billion increased 8%. Earnings per diluted share of $10.44 increased $1.52. Adjusted Earnings per Diluted Share of $11.68 increased 18%. Generated $3.1 billion of cash ...
Approve, download and pay all pharmaceutical product purchases with the payables management module in the McKesson Connect online ordering platform for pharmacies. View, approve, download, print and ...
Over the last 20 years, McKesson has been advancing cancer care by empowering community providers to maintain their independence so patients can get high-quality care closer to home, while partnering ...
These efforts reflect a shared commitment to apply AI thoughtfully to reduce complexity and strengthen the systems patients rely on. The healthcare system’s intricate web of tasks and processes often ...
Oncologists are treating nearly twice as many patients with cell and gene therapies (CGTs) as they were in 2024, and 97% say CGTs could offer some patients the best chance for a cure. This year, the ...
Pharmacies operate within a complex environment of contracts, credentialing requirements, rules and reimbursement systems that few outside the industry ever see. Pharmacy Services Administrative ...
At LogiPharma USA 2026, McKesson leaders Chris Van Norman and Nicole Wade participated in the panel, “Racing to Meet the Moment: Supply Chains Built for Today’s Therapies.” The discussion highlighted ...
McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...
NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...
IRVING, Texas, November 5, 2025 - McKesson Corporation (NYSE:MCK) today announced results for the second quarter ended September 30, 2025. Quarterly consolidated revenues increased to a record high of ...
Consolidated revenues of $97.8 billion increased 23%. Earnings per diluted share of $6.25 decreased $0.75. Adjusted Earnings per Diluted Share of $8.26 increased 5%. McKesson completed the ...
IRVING, Texas, May 7, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the fourth quarter and fiscal year ended March 31, 2026. Consolidated revenues of $96.3 billion increased 6%.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results